Akebia Therapeutics (NASDAQ:AKBA) Stock Falls 78% In a Month: But Why?

April 18, 2022

The past month has been a bit of a disaster for investors in the Akebia Therapeutics (NASDAQ:AKBA) stock as it suffered from an almighty selloff and went down by as much as 78%. In this context, it may be a good idea to take a look at some of the recent developments with regards to the company’s potentially blockbuster product vadadustat last month. Trading Data On Thursday, AKBA stock moved…